Per Sauerberg

2.5k total citations
74 papers, 2.0k citations indexed

About

Per Sauerberg is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Per Sauerberg has authored 74 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Molecular Biology, 34 papers in Cellular and Molecular Neuroscience and 12 papers in Physiology. Recurrent topics in Per Sauerberg's work include Receptor Mechanisms and Signaling (45 papers), Neuroscience and Neuropharmacology Research (18 papers) and Peroxisome Proliferator-Activated Receptors (17 papers). Per Sauerberg is often cited by papers focused on Receptor Mechanisms and Signaling (45 papers), Neuroscience and Neuropharmacology Research (18 papers) and Peroxisome Proliferator-Activated Receptors (17 papers). Per Sauerberg collaborates with scholars based in Denmark, United States and Australia. Per Sauerberg's co-authors include Malcolm J. Sheardown, Lone Jeppesen, Michael D.B. Swedberg, Harlan E. Shannon, Jan Fleckner, Preben H. Olesen, Charles H. Mitch, Anders Fink‐Jensen, Frank P. Bymaster and John S. Ward and has published in prestigious journals such as PLoS ONE, Brain Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Per Sauerberg

73 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Per Sauerberg Denmark 27 1.5k 887 302 253 247 74 2.0k
W. Soudijn Netherlands 29 1.2k 0.8× 899 1.0× 239 0.8× 379 1.5× 166 0.7× 98 2.4k
Elena Poggesi Italy 24 746 0.5× 484 0.5× 215 0.7× 347 1.4× 119 0.5× 54 1.5k
Winnie Deuther‐Conrad Germany 26 1.3k 0.9× 579 0.7× 454 1.5× 411 1.6× 403 1.6× 159 2.5k
Gilbert Lavielle France 25 768 0.5× 679 0.8× 193 0.6× 460 1.8× 344 1.4× 55 1.9k
Akinobu Nagaoka Japan 25 1.2k 0.8× 980 1.1× 618 2.0× 217 0.9× 271 1.1× 104 2.7k
Stanislav Tuček Czechia 25 1.4k 0.9× 1.2k 1.3× 279 0.9× 94 0.4× 371 1.5× 65 2.1k
Laura Rauser United States 10 552 0.4× 433 0.5× 158 0.5× 161 0.6× 226 0.9× 11 1.4k
Patricia Salvati Italy 23 574 0.4× 405 0.5× 270 0.9× 450 1.8× 444 1.8× 61 2.0k
Tino Dyhring Denmark 19 1.3k 0.8× 649 0.7× 222 0.7× 118 0.5× 254 1.0× 39 1.7k
David O. Calligaro United States 28 1.2k 0.8× 1.2k 1.4× 400 1.3× 260 1.0× 287 1.2× 75 2.4k

Countries citing papers authored by Per Sauerberg

Since Specialization
Citations

This map shows the geographic impact of Per Sauerberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Sauerberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Sauerberg more than expected).

Fields of papers citing papers by Per Sauerberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Per Sauerberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Sauerberg. The network helps show where Per Sauerberg may publish in the future.

Co-authorship network of co-authors of Per Sauerberg

This figure shows the co-authorship network connecting the top 25 collaborators of Per Sauerberg. A scholar is included among the top collaborators of Per Sauerberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Per Sauerberg. Per Sauerberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Simonsen, Lotte, Jesper Lau, Thomas Kruse, et al.. (2022). Preclinical evaluation of a protracted GLP-1/glucagon receptor co-agonist: Translational difficulties and pitfalls. PLoS ONE. 17(3). e0264974–e0264974. 26 indexed citations
2.
Harpsøe, Kasper, Jesper Mosolff Mathiesen, Christina Mølck, et al.. (2012). Structure–Activity Relationships for Negative Allosteric mGluR5 Modulators. ChemMedChem. 7(3). 440–451. 16 indexed citations
3.
Ye, Ji‐Ming, Nigel Turner, Xiao‐Yi Zeng, et al.. (2011). PPARδ agonists have opposing effects on insulin resistance in high fat‐fed rats and mice due to different metabolic responses in muscle. British Journal of Pharmacology. 163(3). 556–566. 23 indexed citations
4.
Winzell, Maria Sörhede, Erik Max Wulff, Grith Skytte Olsen, et al.. (2009). Improved insulin sensitivity and islet function after PPARδ activation in diabetic db/db mice. European Journal of Pharmacology. 626(2-3). 297–305. 34 indexed citations
5.
Larsen, Philip J., Kirsten Lykkegaard, Leif K. Larsen, et al.. (2008). Dissociation of antihyperglycaemic and adverse effects of partial perioxisome proliferator-activated receptor (PPAR-γ) agonist balaglitazone. European Journal of Pharmacology. 596(1-3). 173–179. 34 indexed citations
6.
Harpsøe, Kasper, J.S. Kastrup, Darryl S. Pickering, et al.. (2007). Structural Proof of a Dimeric Positive Modulator Bridging Two Identical AMPA Receptor-Binding Sites. Chemistry & Biology. 14(11). 1294–1303. 52 indexed citations
7.
Sauerberg, Per, et al.. (2007). Novel selective PPARδ agonists: Optimization of activity by modification of alkynylallylic moiety. Bioorganic & Medicinal Chemistry Letters. 17(15). 4144–4149. 10 indexed citations
8.
Sauerberg, Per, John P. Mogensen, Lone Jeppesen, et al.. (2007). Design of potent PPARα agonists. Bioorganic & Medicinal Chemistry Letters. 17(11). 3198–3202. 13 indexed citations
9.
Frederiksen, Klaus Stensgaard, Erik Max Wulff, Per Sauerberg, et al.. (2004). Prediction of PPAR-α ligand-mediated physiological changes using gene expression profiles. Journal of Lipid Research. 45(3). 592–601. 53 indexed citations
10.
Wassermann, Karsten, et al.. (2003). Identification of hepatic transcriptional changes in insulin-resistant rats treated with peroxisome proliferator activated receptor-alpha agonists. Journal of Molecular Endocrinology. 30(3). 317–329. 27 indexed citations
11.
Thor, Karl B., Mark Muhlhauser, Per Sauerberg, Harlan E. Shannon, & Johannes P. Springer. (2000). Central muscarinic inhibition of lower urinary tract nociception. Brain Research. 870(1-2). 126–134. 11 indexed citations
12.
Shannon, Harlan E., Kurt Rasmussen, Neil W. DeLapp, et al.. (1998). Unexpected antipsychotic-like activity with the muscarinic receptor ligand (5R,6R)6-(3-propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1]octane. European Journal of Pharmacology. 356(2-3). 109–119. 53 indexed citations
13.
Bymaster, Frank P., Steven Peters, Wei Zhang, et al.. (1998). Xanomeline compared to other muscarinic agents on stimulation of phosphoinositide hydrolysis in vivo and other cholinomimetic effects. Brain Research. 795(1-2). 179–190. 56 indexed citations
14.
Shannon, Harlan E., Malcolm J. Sheardown, Frank P. Bymaster, et al.. (1997). Pharmacology of Butylthio[2.2.2] (LY297802/NNC11-1053): A Novel Analgesic with Mixed Muscarinic Receptor Agonist and Antagonist Activity. Journal of Pharmacology and Experimental Therapeutics. 281(2). 884–894. 22 indexed citations
15.
Olesen, Preben H., Per Sauerberg, Svend Treppendahl, et al.. (1997). Synthesis and structural determination of stereoisomers of muscarinic ligands of the (3-propylthio-1,2,5-thiadiazol-4-yl)-1-azabicycloalkane type. Chirality. 9(8). 739–749. 5 indexed citations
16.
Sauerberg, Per, Preben H. Olesen, Svend Treppendahl, et al.. (1992). Novel functional M1 selective muscarinic agonists. Synthesis and structure-activity relationships of 3-(1,2,5-thiadiazolyl)-1,2,5,6-tetrahydro-1-methylpyridines. Journal of Medicinal Chemistry. 35(12). 2274–2283. 131 indexed citations
17.
18.
Sauerberg, Per, Jake Y. Chen, Elizabeth WoldeMussie, & Henry Rapoport. (1989). Cyclic carbamate analogs of pilocarpine. Journal of Medicinal Chemistry. 32(6). 1322–1326. 20 indexed citations
19.
Krogsgaard‐Larsen, Povl, et al.. (1988). Bioisosteres of arecoline as novel CNS-active muscarinic agonists.. PubMed. Suppl. 69–74. 2 indexed citations
20.
Sauerberg, Per, et al.. (1988). Heterocyclic muscarinic agonists. Synthesis and biological activity of some bicyclic sulfonium arecoline bioisosteres. Journal of Medicinal Chemistry. 31(7). 1312–1316. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W. Soudijn Breakdown of academic impact, for papers by Elena Poggesi Breakdown of academic impact, for papers by Winnie Deuther‐Conrad Breakdown of academic impact, for papers by Gilbert Lavielle Breakdown of academic impact, for papers by Akinobu Nagaoka Breakdown of academic impact, for papers by Stanislav Tuček Breakdown of academic impact, for papers by Laura Rauser Breakdown of academic impact, for papers by Patricia Salvati Breakdown of academic impact, for papers by Tino Dyhring Breakdown of academic impact, for papers by David O. Calligaro
Rankless by CCL
2026